Karyopharm Therapeutics reported $302.49M in Loan Capital for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Loan Capital Change
Abbott ABT:US $ 17086M 210M
Abbvie ABBV:US $ 63522M 667M
Amgen AMGN:US $ 36010M 2788M
AstraZeneca AZN:LN 28805M 83M
Astrazeneca AZN:US 28.81B 83M
Avrobio Inc AVRO:US $ 15.02M 75K
Biocryst Pharmaceuticals BCRX:US $ 604.46M 19M
Bristol Myers Squibb BMY:US $ 37450M 2155M
Eli Lilly And LLY:US $ 15152.9M 193.5M
Enanta Pharmaceuticals ENTA:US $ 1.51M 0M
Epizyme EPZM:US $ 232.49M 379K
GlaxoSmithKline GSK:LN 29226M 8654M
Johnson & Johnson JNJ:US $ 28851M 1134M
Karyopharm Therapeutics KPTI:US $ 302.49M 198K
Macrogenics MGNX:US $ 0 0
Merk MRK:US $ 30586M 104M
Mirati Therapeutics MRTX:US $ 0M 0M
Nektar Therapeutics NKTR:US $ 0M 0M
Novartis NVS:US $ 24373M 150M
Novartis NOVN:VX SF 24373M 150M
Regeneron Pharmaceuticals REGN:US $ 2700.4M 720.4M
Sangamo Biosciences SGMO:US $ 0M 0M
Takeda 4502:JP Y 4141418M 90521M
Tg Therapeutics TGTX:US $ 67.25M 0.46M
Ultragenyx Pharmaceutical RARE:US $ 0M 0.41M
Xencor XNCR:US $ 0M 0M
YTE INCY:US $ 31.38M 0.25M